Veterinary Anti-Infectives Market Research Report 2017-2025

Global Market Study
on Veterinary AntiInfectives:
Antiparasitic Agents Segment Expected to be the Least Attractive
Segment by Drug Class
With growing occurrence of zoonotic and food borne diseases in countries like
MEA, is one of the factor influencing the demand of the attenuated live
vaccines section in the region. The countries contained within the Central
Europe and MEA region are highly reliant on the live stock trade as a resource
of survival. Meat and milk are few of the general resources resultant of animal
husbandry measures bring about in these regions.
Market Segmentation
The worldwide veterinary vaccines market is broadly segmented into vaccine
type, disease indication, animal type, distribution channel and by country.
Browse Full Research Report:
https://www.persistencemarketresearch.com/market-research/veterinary-antiinfectives-market.asp
Forecast by market type
Based on the market type, the market is sub-segmented into inactivated
vaccines, recombinant vaccines, DNA vaccines, attenuated live vaccines, toxoid
vaccines and others. The attenuated live vaccines division was the biggest
division as compare to other market type category. In 2016, the market was
anticipated to generate nearly US$ 90 million and is estimated to reach above
US$ 150 million at the end of forecast period 2026. The segment is likely to
record a remarkable CAGR of 5.8% during the estimated period.
Forecast by disease indication
The worldwide market, based on disease indication includes new castle disease,
foot and mouth disease, canine parvovirus, PPRS, avian influenza, brucellosis
and others. The foot and mouth disease is likely to account for veterinary
vaccines over 25% of revenues collected from the MEA region throughout the
projected period.
Request and Download Sample Report@
https://www.persistencemarketresearch.com/samples/17014
Forecast by animal type
The overall veterinary vaccines market includes canine, companion animals,
feline, avian, aquatic, livestock animals, porcine, bovine, equine, poultry and
small ruminant.
Forecast by distribution channel
The veterinary vaccines are distributed through veterinary clinics, hospital
pharmacies, private veterinary pharmacies and others.
Forecast by Country
The worldwide market is studied across the seven prominent regions
• Kingdom of Saudi Arabia
• United Arab Emirates
• Jordan
• Turkey
• Egypt
• Sudan
• Rest of MEA
Among other regions, the UAE, Egypt, Turkey and Jordan are the main markets
in the Middle East and African region. The MEA region at present is valued
about US$ 267.3 Mn and is likely to grow at a steady rate by reaching nearly
US$ 422.9 Mn in terms of value by the end of the assessment period 2026 as
well as exhibiting a moderate 4.7% CAGR. The Jordan region is anticipated to
lead the overall MEA market by recording a value share of US$88 Mn.
Key Market Players
The worldwide players in the veterinary vaccines market includes
• Merial
• Bioveta Inc.
• Ceva
• Bayer Healthcare AG
• Zoetis
• Intervac Pvt. Ltd.
• Merck & Co, Inc.
• Elanco
Buy Full Veterinary Anti-Infectives Market Report
@ https://www.persistencemarketresearch.com/checkout/17014
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our
research model is a unique collaboration of data analytics and market research
methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from
multi-dimensional sources. By deploying real-time data collection, big data, and
customer experience analytics, we deliver business intelligence for
organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com

North America is currently the largest veterinary anti-infectives market and is estimated to represent 30.5% value share of the global market by 2025-end, expanding at CAGR of 3.7%.